Analysis of immunoglobulin, T cell receptor and cytokine genes in hematologic neoplasms
血液肿瘤中免疫球蛋白、T细胞受体和细胞因子基因分析
基本信息
- 批准号:61480260
- 负责人:
- 金额:$ 4.48万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1986
- 资助国家:日本
- 起止时间:1986 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Rearrangements of immunoglobulin (Ig) or T cell receptor (TCR) chain gene were observed in all of lymph node cells from phenotypically undetermined cell lymphoma, suggesting that demonstration of these gene rearrangements is a powerful tool to determine cell lineage and clonality. TCR chain gene rearrangement was frequently found in both T cell and immature B cell neoplasms and was not observed in mature B cell neoplasms. Furthermore, rearrangement of TCR chain gene was also found in immature B cell leukemias associated with TCR chain gene rearrangement. These results indicate that an analysis of Ig and TCR gene provides a potential tool to identify the normal stages of lymphocyte differentiation. The density of TCR and CD3 antigens on adult T cell leukemia (ATL) cells are low, indicating that interactions of atnigents to CD3-TCR complex induce their modulation. No significant homologies were noted among the deduced amino acid sequences of variable lesions of TCR chain, and the plofiles of rearrangement patterns of TCR and chain gene in ATL cells were heterogenous. However, there were apparent associations between a defect of expression of CD3-TCR complex and identical genotypes of fresh and cultured cells, suggesting that the defect of expression of CD3-TCR complex may play a key role for development of ATL. On the other hand, a significant proliferation by IL-1, which were inhibited by anti-IL-1 antibody, was observed in cells from a patient with myeloid leukemia. Culture supernatants of these leukemic cells contained IL-1 activity and northern blot analysis detected intracellular IL-1 mRNA, indicating that autocrine secretion of IL-1 was involved in proliferation of some myeloid leukemic cells. Thus, an analysis of Ig, TCR and cytokine genes is a powerful tool to classify and characterize hematologic neoplasms.
免疫球蛋白(IG)或T细胞受体(TCR)链基因重排在所有表型未定细胞淋巴瘤的淋巴结细胞中均被观察到,提示这些基因重排的证明是确定细胞谱系和克隆性的有力工具。TCR链基因重排在T细胞和未成熟B细胞肿瘤中经常发现,而在成熟B细胞肿瘤中未观察到。此外,在未成熟B细胞白血病中也发现了TCR链基因重排。这些结果表明,IG和TCR基因的分析提供了一个潜在的工具,以确定淋巴细胞分化的正常阶段。成人T细胞白血病(ATL)细胞表面TCR和CD 3抗原密度较低,表明补体与CD 3-TCR复合物的相互作用诱导了它们的调节。在ATL细胞中,TCR链可变区的氨基酸序列之间没有明显的同源性,TCR和链基因重排模式的谱图是异质性的。然而,CD 3-TCR复合物的表达缺陷与新鲜细胞和培养细胞的相同基因型之间存在明显的相关性,表明CD 3-TCR复合物的表达缺陷可能在ATL的发生中起关键作用。另一方面,在来自骨髓性白血病患者的细胞中观察到IL-1的显著增殖,其被抗IL-1抗体抑制。这些白血病细胞的培养上清含有IL-1活性,北方印迹分析检测到细胞内IL-1 mRNA,表明IL-1的自分泌参与了某些髓系白血病细胞的增殖。因此,分析IG、TCR和细胞因子基因是对血液肿瘤进行分类和表征的有力工具。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Norio,Asou; Masao,Matsuoka; Toshio,Hattori; Fumio,Kawano; Shuichiro,Maeda; Kazunori,Shimada; Kiyoshi,Takatsuki: "T cell gamma chain gene rearrangement without T cell receptor beta chain gene rearrangement in two cases of non-Hodgkin's lymphoma" BLOOD. 77.
纪夫、麻生;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Norio Asou;Masao Matsucka;Tosho Hattori;Kiyoshi Takatsuki: Blood. 69. 968-970 (1987)
麻生纪男、松花正夫、服部敏郎、高槻清:血。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kenji Sakai;Toshio Hattori;Masao Matsuoka;Kiyoshi Takatsuki: J.Exp Med. 166. 1597-1602 (1987)
Kenji Sakai;Toshio Hattori;Masao Matsuoka;Kiyoshi Takatsuki:J.Exp Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kenji Shirono,;Toshio Hattori Masao Matsuoka,;Morio Asou,;Kiyoshi Takatsuki.他: LEUKEMIA. 2. 728-733 (1988)
Kenji Shirono,;Toshio Hattori Masao Matsuoka,;Morio Asou,;Kiyoshi Takatsuki.等:白血病。 2. 728-733 (1988)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsuoka Masao;M.Hacrya;Toshio Hattori;Kiyoshi Takatsuki: Leukemia. 2. (1988)
松冈正男;M.Hacrya;服部俊雄;高槻清:白血病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKATSUKI Kiyoshi其他文献
TAKATSUKI Kiyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKATSUKI Kiyoshi', 18)}}的其他基金
Comparative study of ATL and HTLV-I related disorders
ATL和HTLV-I相关疾病的比较研究
- 批准号:
04042015 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
The equilibrium and control of cell proliferation, Survival and death in chronic hematological neoplasms
慢性血液肿瘤细胞增殖、生存和死亡的平衡与控制
- 批准号:
04454573 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
A study of adult T cell leukemia
成人 T 细胞白血病的研究
- 批准号:
01044116 - 财政年份:1989
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Genetic and molecular studies on the oncogenesis of hematopoietic malignancies
造血系统恶性肿瘤发生的遗传学和分子研究
- 批准号:
01480301 - 财政年份:1989
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
AVM0703 combined with Non-Hodgkin's Lymphoma standard of care to enhance complete response rates without additional toxicities
AVM0703 与非霍奇金淋巴瘤护理标准相结合,可提高完全缓解率,且不会产生额外毒性
- 批准号:
10546563 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients
针对复发/难治性“无选择”非霍奇金淋巴瘤/白血病患者的快速扩展队列临床试验
- 批准号:
10482324 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients
针对复发/难治性“无选择”非霍奇金淋巴瘤/白血病患者的快速扩展队列临床试验
- 批准号:
10642955 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
非霍奇金淋巴瘤伊布替尼耐药的介导机制
- 批准号:
9237831 - 财政年份:2017
- 资助金额:
$ 4.48万 - 项目类别:
Development of a Coiled-Coil therapeutic for Non-Hodgkin's Lymphoma
开发用于非霍奇金淋巴瘤的螺旋线圈疗法
- 批准号:
8698611 - 财政年份:2014
- 资助金额:
$ 4.48万 - 项目类别:
Development of a Coiled-Coil therapeutic for Non-Hodgkin's Lymphoma
开发用于非霍奇金淋巴瘤的螺旋线圈疗法
- 批准号:
8933950 - 财政年份:2014
- 资助金额:
$ 4.48万 - 项目类别:
Chronic Fatigue Syndrome, Immune Dysregulation, and Non-Hodgkin's Lymphoma
慢性疲劳综合症、免疫失调和非霍奇金淋巴瘤
- 批准号:
8688387 - 财政年份:2014
- 资助金额:
$ 4.48万 - 项目类别:
Therapeutic vaccine against non-Hodgkin's lymphoma targeting the immune adjuvant properties of Natural Killer T cells.
针对非霍奇金淋巴瘤的治疗性疫苗,针对自然杀伤 T 细胞的免疫佐剂特性。
- 批准号:
nhmrc : 1044355 - 财政年份:2013
- 资助金额:
$ 4.48万 - 项目类别:
Project Grants
Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin's lymphoma
非霍奇金淋巴瘤中 microRNA 的分子流行病学/功能分析
- 批准号:
8106946 - 财政年份:2011
- 资助金额:
$ 4.48万 - 项目类别:
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
一种新的小分子靶向剂和非霍奇金淋巴瘤的治疗方法
- 批准号:
8930077 - 财政年份:2011
- 资助金额:
$ 4.48万 - 项目类别: